Tel:
Fax:
Email:
Creative Biolabs
Product

NeuroMab™ Anti-IL-6 BBB Shuttle Antibody (NRZP-1022-ZP2895)

[CAT#: NRZP-1022-ZP2895]

Host Species:
Mouse; Humanized; Chimeric
Species Reactivity:
Human
Applications:
Antagonist; In Vivo; In Vitro; Block; Inhib

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

SPECIFIC INQUIRY

inquiry
Size:
Conjugation:
Endotoxin:
Purity:
Engineering:
Product Overview

Description

Brain uptake of therapeutic antibodies is severely limited by their size. To achieve enhanced BBB crossing, Creative Biolabs developed a BBB shuttle antibody platform by utilizing the endogenous macromolecule transportation pathway, known as receptor-mediated transcytosis (RMT). The engineered antibody-based carrier is believed to significantly to increase the macromolecule brain entry to combat CNS diseases.
Notes: The BBB antibody is made-to order and available in a customized format. Please don't hesitate contact us for more details.

Immunogen

IL-6/IL-6Ralpha Complex

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Mouse; Humanized; Chimeric

Applications

Antagonist; In Vivo; In Vitro; Block; Inhib
Product Properties

Storage

Store at -20°C. Do not aliquot the antibody.

Research Use Only

For research use only
Target

Target

IL-6

Official Name

IL6

Full Name

Interleukin 6 (IL-6)

Alternative Names

IL6; BSF2; HGF; HSF; IFNB2; IL-6; BSF-2; CDF; IFN-beta-2; interleukin 6
Product Pictures
Inhib

Figure 8 shows the results of experiments reflecting the in vivo inhibition of haptoglobin secretion by exemplary antibodies.

ELISA

Figure 1 shows the results of experiments reflecting the binding of exemplary antibodies to Fc-IL6Ralpha-IL6.

ELISA

Figure 2 shows the results of experiments reflecting the binding of exemplary antibodies to IL-6.

ELISA

Figure 3 shows the results of experiments reflecting the binding of exemplary antibodies of the invention to non-covalently complexed IL-6 and IL-6Rα.

Block

Figure 4 shows the results of experiments illustrating the ability of exemplary antibodies to block haptoglobin release from HepG2 cells stimulated with Fc-IL6Ralpha-IL6 complexes.

FuncS

Figure 6 shows the results of experiments reflecting the binding of exemplary antibodies to IL-6Ralpha alone.

FuncS

Figure 7 illustrates the pharmacokinetic properties of exemplary antibodies.

Inhib

Figure 9 shows the experimental results reflecting inhibition of lung metastasis.

Publications

Publications (0)

gift-card

Related Products
For Research Use Only. Not For Clinical Use.
Send Inquiry Send Inquiry
Inquiry Basket
compare

Send inquiry